These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Herrmann ML; Schleyerbach R; Kirschbaum BJ Immunopharmacology; 2000 May; 47(2-3):273-89. PubMed ID: 10878294 [TBL] [Abstract][Full Text] [Related]
5. Leflunomide: a novel disease modifying anti-rheumatic drug. Kale VP; Bichile LS J Postgrad Med; 2004; 50(2):154-7. PubMed ID: 15235221 [No Abstract] [Full Text] [Related]
6. [Leflunomide: a new treatment for an old disease]. Monteagudo Sáez I; López Longo FJ; González Fernández CM; Carreño Pérez L Rev Clin Esp; 2000 May; 200 Monog 1():114-8. PubMed ID: 10901036 [No Abstract] [Full Text] [Related]
7. Leflunomide: a review of its use in active rheumatoid arthritis. Prakash A; Jarvis B Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393 [TBL] [Abstract][Full Text] [Related]
8. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525 [TBL] [Abstract][Full Text] [Related]
9. Leflunomide. Cohen SB; Iqbal I Int J Clin Pract; 2003 Mar; 57(2):115-20. PubMed ID: 12661795 [TBL] [Abstract][Full Text] [Related]
10. [Leflunomide for therapy of rheumatoid arthritis]. Nakajima A; Yamanaka H Nihon Rinsho; 2005 Jan; 63 Suppl 1():493-7. PubMed ID: 15799405 [No Abstract] [Full Text] [Related]
11. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model. Bae J; Park JW Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334 [TBL] [Abstract][Full Text] [Related]
12. Leflunomide. Cannon GW; Kremer JM Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Weinblatt ME; Kremer JM; Coblyn JS; Maier AL; Helfgott SM; Morrell M; Byrne VM; Kaymakcian MV; Strand V Arthritis Rheum; 1999 Jul; 42(7):1322-8. PubMed ID: 10403258 [TBL] [Abstract][Full Text] [Related]
14. Leflunomide-induced polymyositis in a patient with rheumatoid arthritis. Ochi S; Taniguchi K; Nagashima M Mod Rheumatol; 2009; 19(4):443-6. PubMed ID: 19526307 [TBL] [Abstract][Full Text] [Related]
15. Effects of leflunomide on immune responses and models of inflammation. Bartlett RR; Anagnostopulos H; Zielinski T; Mattar T; Schleyerbach R Springer Semin Immunopathol; 1993; 14(4):381-94. PubMed ID: 8322168 [No Abstract] [Full Text] [Related]
16. Leflunomide and hypertension. Rozman B; Praprotnik S; Logar D; Tomsic M; Hojnik M; Kos-Golja M; Accetto R; Dolenc P Ann Rheum Dis; 2002 Jun; 61(6):567-9. PubMed ID: 12006342 [No Abstract] [Full Text] [Related]
18. Leflunomide for rheumatoid arthritis. Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115 [TBL] [Abstract][Full Text] [Related]
19. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Breedveld FC; Dayer JM Ann Rheum Dis; 2000 Nov; 59(11):841-9. PubMed ID: 11053058 [TBL] [Abstract][Full Text] [Related]
20. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients. Gupta R; Bhatia J; Gupta SK Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]